enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. List of Schedule II controlled substances (U.S.) - Wikipedia

    en.wikipedia.org/wiki/List_of_Schedule_II...

    Drug 9050 opiate Codeine [2] 9334 opiate Dihydroetorphine [3] 9190 opiate Ethylmorphine [2] 9059 opiate Etorphine hydrochloride [4] 9640 opiate Granulated opium [2] 9193 opiate Hydrocodone [2] 9150 opiate Hydromorphone [2] 9260 opiate Metopon [2] 9300 opiate Morphine [2] 9668 opiate Noroxymorphone [5] 9610 opiate Opium extracts [2] 9620 opiate ...

  3. Memantine - Wikipedia

    en.wikipedia.org/wiki/Memantine

    Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. [10] [11] [8] It is taken by mouth. [10] [8] Common side effects include headache, constipation, sleepiness, and dizziness. [10] [11] Severe side effects may include blood clots, psychosis, and heart ...

  4. Drug Price Competition and Patent Term Restoration Act

    en.wikipedia.org/wiki/Drug_Price_Competition_and...

    With time the law became successful in promoting the introduction of generics; in 1983 only 35% of top-selling branded drugs with expired patents had generic competition, and only 13% of prescriptions were for generics but in 2012, 84% of prescriptions in the US were filled with generic drugs.

  5. GlaxoSmithKline, Sanofi-Aventis: Rx for When Drug Patents Expire

    www.aol.com/news/2010-03-31-glaxosmithkline...

    In the Phase II trial, the PFS of patients receiving ARQ 197 in combination with erlotinib (the standard treatment) was 16.1 weeks, compared with 9.7 weeks for patients receiving erlotinib only.

  6. Forest Laboratories - Wikipedia

    en.wikipedia.org/wiki/Forest_Laboratories

    [2] In 1967, the company became a public company via an initial public offering. [3] Ten years later, Howard Solomon became the chief executive officer of the company. [3] In 1984, the company acquired O'Neal Jones & Feldman for $8.8 million after a federal investigation resulted in one of its drugs being recalled. [4] [2]

  7. List of drugs granted breakthrough therapy designation

    en.wikipedia.org/wiki/List_of_drugs_granted...

    class II-III obstructive hypertrophic cardiomyopathy: Trastuzumab deruxtecan: Daiichi Sankyo: granted for three indications: HER2-positive breast cancer with prior anti-HER2-based treatment; HER2 low (IHC 1+ or IHC 2+/ISH) breast cancer; and non-small cell-lung cancer with an activating HER2 mutation Dupilumab: Regeneron Pharmaceuticals

  8. Nitromemantine - Wikipedia

    en.wikipedia.org/wiki/Nitromemantine

    Like memantine, nitromemantine is a low-affinity voltage-dependent uncompetitive antagonist at glutamatergic NMDA receptors, however nitromemantine selectively inhibits extrasynaptic NMDA receptors while sparing normal physiological synaptic NMDA receptor activity, resulting in less side effects and a greater neuroprotective action, as well as stimulating regrowth of synapses with prolonged ...

  9. List of psychotropic medications - Wikipedia

    en.wikipedia.org/wiki/List_of_psychotropic...

    Keppra (levetiracetam) – an anticonvulsant drug which is sometimes used as a mood stabilizer and has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome, anxiety disorder, and Alzheimer's disease; Klonopin – anti-anxiety and anti-epileptic medication of the benzodiazepine class